Artelo Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Artelo Biosciences has a total shareholder equity of $7.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.3M and $1.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.60m |
| Equity | US$7.30m |
| Total liabilities | US$1.03m |
| Total assets | US$8.33m |
Recent financial health updates
Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
Mar 28
Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Nov 02Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
May 20Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Feb 04Recent updates
Artelo jumps 21% as publication highlights pre-clinical data on drug platform
Aug 16Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
Mar 28Artelo Biosciences Rounding A Corner With Cannabinoid-Based Therapy
Mar 09Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Nov 02Relief For Cancer Patients In Artelo Bioscience Pipeline
Jul 12Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
May 20Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Feb 04INO, VXRT, BTU and TTM among premarket gainers
Feb 02Artelo Biosciences EPS misses by $0.04
Jan 14Artelo Biosciences on go with cancer appetite recovery study
Nov 16Financial Position Analysis
Short Term Liabilities: ARTL's short term assets ($6.2M) exceed its short term liabilities ($940.0K).
Long Term Liabilities: ARTL's short term assets ($6.2M) exceed its long term liabilities ($87.0K).
Debt to Equity History and Analysis
Debt Level: ARTL is debt free.
Reducing Debt: ARTL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ARTL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ARTL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.8% each year